SCLC, LIMITED STAGE
Clinical trials for SCLC, LIMITED STAGE explained in plain language.
Never miss a new study
Get alerted when new SCLC, LIMITED STAGE trials appear
Sign up with your email to follow new studies for SCLC, LIMITED STAGE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for lung cancer patients: durvalumab after chemoradiotherapy shows promise
Disease control Recruiting nowThis study looks at whether the drug durvalumab can safely help control limited-stage small cell lung cancer after initial chemoradiotherapy. Researchers will review medical records of 25 patients who received durvalumab as a follow-up treatment. The main goal is to check for ser…
Matched conditions: SCLC, LIMITED STAGE
Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated May 22, 2026 14:01 UTC
-
Promising new scan may spot lung cancer more precisely
Diagnosis Recruiting nowThis study tests a new radioactive probe called PFD3 that targets a protein (DLL3) found on small cell lung cancer cells. Using PET/CT scans, doctors hope to see tumors more clearly and assess the cancer's spread. About 30 adults with confirmed small cell lung cancer will receive…
Matched conditions: SCLC, LIMITED STAGE
Phase: PHASE1, PHASE2 • Sponsor: Peking University First Hospital • Aim: Diagnosis
Last updated May 15, 2026 11:53 UTC